[27-07-am] Absorption, Controlled Release/Targeting, Pharmacotherapy (Oncology), Pharmacoepidemiology, Health Economics

9:18 AM - 9:30 AM JST(12:18 AM - 12:30 AM UTC)

[27-07-am05S] Medical costs for patients with large vessel vasculitis after approval for Tocilizumab in Japan

○Miyuki Jinnouchi¹, Sari Horiuchi¹, Yukumitsu Kudo¹, Kotaro Kawano¹, Takahiko Sugihara², Ryosuke Kumazawa¹, Ryoko Sakai¹, Manabu Akazawa¹ (1. Meiji pharmaceutical University, 2. Toho University)